UK markets closed

Marvel Biosciences Corp. (MRVL.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.1450-0.0100 (-6.45%)
At close: 02:48PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/07/2023
31/07/2022
31/07/2021
31/07/2020
Total revenue
0
0
0
0
0
Cost of revenue
1,145
887.516
1,377
613.099
265.2
Gross profit
-1,145
-887.516
-1,377
-613.099
-265.2
Operating expenses
Selling general and administrative
1,182
1,409
1,118
634.315
750.902
Total operating expenses
1,182
1,361
1,171
485.043
689.571
Operating income or loss
-2,327
-2,248
-2,548
-1,098
-954.771
Interest expense
62.878
34.591
0
-
-
Total other income/expenses net
-14.485
-4.782
-4.311
-1,939
-0.57
Income before tax
-2,340
-2,291
-2,554
-3,039
-955.657
Income from continuing operations
-2,340
-2,291
-2,554
-3,039
-955.657
Net income
-2,340
-2,291
-2,554
-3,039
-955.657
Net income available to common shareholders
-2,340
-2,291
-2,554
-3,039
-955.657
Basic EPS
-0.06
-0.06
-0.08
-0.17
-0.03
Diluted EPS
-0.06
-0.06
-0.08
-0.17
-0.03
Basic average shares
39,785
39,660
32,759
17,697
32,586
Diluted average shares
39,786
39,660
32,759
17,697
32,586